Biotech School: How To Spot Hidden Danger Signs In Clinical Trial Data

Boys and girls, the bell has rung so please take your seats. In today's class, I'm going to teach you how to dig into clinical trial data to find the red flags and bad stuff biotech companies don't want you to see.

Northwest Biotherapeutics (NWBO) will be the case study for today's lesson. On Wednesday, the company presented an update from a phase I study of DCVax-Direct, a personalized cancer vaccine.

Back to news